Hong, 30 patient HCQ late treatment PSM study: 25% faster recovery [p=0.45], 13% longer hospitalization [p=0.75], and no change in viral clearance [p=0.99] https://c19p.org/hong2
copied to clipboard
Use of combined treatment of 3rd-generation cephalosporin, azithromycin and antiviral agents on moderate SARs-CoV-2 patients in South Korea: A retrospective cohort study
et al., PLOS ONE, doi:10.1371/journal.pone.0267645
Retrospective 25 hospitalized patients treated with cephalosporin, azithromycin, and HCQ, and 217 SOC patients in South Korea, reporting no significant differences. 5 patients receiving lopinavir/ritonavir and HCQ >5 days were excluded for unknown reasons. HCQ was typically initiated based on progression or side effects from another treatment. Conflicting results are reported. Table 2 indicates 15 CA/HCQ patients after matching, while Table S2 shows 25, and the Table 3 count is blank. S2 appears to incorrectly show before matching results, and the after matching results are missing in Table 3. 200mg HCQ bid.
|
recovery time, 24.9% lower, HR 0.75, p = 0.45, treatment 15, control 15, propensity score matching.
|
|
hospitalization time, 12.7% higher, HR 1.13, p = 0.75, treatment 15, control 15, propensity score matching.
|
|
viral clearance time, 0.5% lower, HR 1.00, p = 0.99, treatment 15, control 15, propensity score matching.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Hong et al., 5/4/2022, retrospective, South Korea, Asia, peer-reviewed, 11 authors, study period 28 February, 2020 - 28 April, 2020.
Contact:
kmedicsoon@pusan.ac.kr, thhwang@pusan.ac.kr, wsabf@naver.com.
Late treatment
is less effective
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.